Salarius Pharmaceuticals Inc

NASDAQ:SLRX   3:53:30 PM EDT
0.50
-0.01 (-1.77%)
5:01:35 PM EDT: $0.51 +0.01 (+2.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Salarius Pharmaceuticals Inc Stock, NASDAQ:SLRX

2450 Holcombe Boulevard, Suite X, Houston, Texas 77021
United States of America
Phone: +1.832.834.6992
Number of Employees: 2
http://salariuspharma.com

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.